Core Insights - The establishment of the "Cell Preparation Quality Evaluation Innovation Center" aims to enhance the quality control of cell-based therapies and address industry challenges through innovative research and collaboration [1][2][3] Group 1: Research and Development Initiatives - The "National Key Laboratory of Drug Regulatory Science" has approved a project focusing on AI-driven dynamic rapid testing methods for stem cell preparation quality control, utilizing self-developed AI technology [1] - The project "Lens-free Digital Chip Microscopy Technology and Biomedical Applications" has been recognized as one of the top ten technological advancements in the biomedicine field in Jiangsu Province for 2024 [1] Group 2: Collaboration and Strategic Goals - The Jiangsu Provincial Drug Supervision and Inspection Research Institute emphasizes the importance of collaboration in technology support, standard formulation, and platform construction for the innovation center [2] - The center aims to bridge the gaps in the "R&D-production-regulation" chain, facilitating high-quality development in the cell therapy industry to meet urgent patient needs [2][3] Group 3: Quality Assurance and Industry Standards - The focus on quality evaluation research for cell preparations is expected to fill industry gaps and provide comprehensive testing services for cell drug developers [3] - The Jiangsu Provincial Drug Supervision and Inspection Research Institute plans to enhance its technical capabilities to ensure a robust quality control system throughout the drug lifecycle [3]